ask our doctors

Lymphoma Mantle Cell

Get the facts on Lymphoma Mantle Cell treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Lymphoma Mantle Cell prevention, screening, research, statistics and other Lymphoma Mantle Cell related topics. We answer all your qestions about Lymphoma Mantle Cell.

Question: Does anyone know what the prognosis for Mantle Cell Lymphoma is? My sister in law has just been diagnosed and has started her Chemotherapy a few days ago. Any information I can find on the internet is quite negative and says that the prognosis is not good. Does anyone know any different? Is it treatable with a good outcome? it is stage 1, I think, so they've got it early.

Answer: Type in Hackensack University Medical Center Lymphoma Mantle Cell. My oncologist is a world renouned researcher in the field of Mantle Cell Lymphoma. He has just come up with an FDA approved drug for fighting Mantle Cell.


Lymphoma Mantle Cell News

Another Year, Another High...

NASDAQ
A number of phase 1 and 2 studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and diffuse large B-cell lymphoma. Last December, the company presented interim ...
 

Eurweb.com

Full Force's Paul Anthony on Why He Revealed Cancer on TV One's 'Unsung'
Eurweb.com
 

Genetic Engineering News

Bortezomib OK'd for SQ Delivery
MedPage Today
 

Nodal Marginal Zone Lymphoma: Impersonalized Medicine

Cancer Network
As described, MZLs as a class overlap significantly with other indolent B-cell lymphomas, with only subtle differences and no universal underlying feature. Expert review has revealed that discordant pathologic rates occur in 5% to 10% of all cases of ...
 

Radar Online

Illinois Teen Overcomes Parents' Cancer Battles To Become Star Wrestler And ...
Radar Online
 

Beacon BreakingNews ? Subcutaneous Velcade Receives FDA Approval

The Myeloma Beacon
Millennium: The Takeda Oncology Company announced today that the US Food and Drug Administration has approved subcutaneous administration of Velcade for the treatment of multiple myeloma and relapsed mantle cell lymphoma. Velcade (bortezomib), which is ...
 

Tubing fundraiser moved to Feb. 6

Echo Pilot
Proceeds will benefit Justin Grove, who at age 33 was diagnosed with Mantle cell, a rare form of non-Hodgkins lymphoma. Tubing hours for the benefit are 4 to 10 pm Due to the rain last Thursday, the Grove Family Fund Spirit Night for snow tubing at ...
 

Financial planning: Facing the final facts

Toronto Star
?I have a rare incurable mantle cell lymphoma,? she says, referring to a type of cancer that begins in the immune system. ?With treatment, my prognosis is about seven to eight years.? Cynthia isn't her real name. She wants to keep a low profile, ...
 

Faith and friends lifting Greencastle's Justin Grove family dealing with illness

Echo Pilot
Grove, 33, was diagnosed in November with Mantle cell, a rare form of non-Hodgkins lymphoma. It usually affects men around the age of 60, and there are only 3000 new cases per year in the United States. Self-employed with his wife Bethany (Riegsecker) ...
 

Did You Buy These Stocks?

NASDAQ
A number of Phase 1 and 2 studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and diffuse large B-cell lymphoma. In December of 2011, Pharmacyclics inked a deal ...